Issue 8/2021
Content (9 Articles)
Is it Time to Expand Glucagon-like Peptide-1 Receptor Agonist Use for Weight Loss in Patients Without Diabetes?
- Overweight
- Current Opinion
Wendy H. Updike, Olivia Pane, Rachel Franks, Faizah Saber, Farah Abdeen, Derek D. Balazy, Nicholas W. Carris
IL-31 Inhibition as a Therapeutic Approach for the Management of Chronic Pruritic Dermatoses
- Atopic Dermatitis
- Leading Article
Youkyung S. Roh, Justin Choi, Nishadh Sutaria, Micah Belzberg, Madan M. Kwatra, Shawn G. Kwatra
Preclinical and Clinical Characteristics of the Trichuricidal Drug Oxantel Pamoate and Clinical Development Plans: A Review
- Open Access
- Albendazole
- Review Article
Marta S. Palmeirim, Sabine Specht, Ivan Scandale, Irene Gander-Meisterernst, Monika Chabicovsky, Jennifer Keiser
Targeting AMPK by Statins: A Potential Therapeutic Approach
- Open Access
- Atorvastatin
- Review Article
Sajad Dehnavi, Amirhossein Kiani, Mahvash Sadeghi, Ali Farhadi Biregani, Maciej Banach, Stephen L. Atkin, Tannaz Jamialahmadi, Amirhossein Sahebkar
Fostamatinib: A Review in Chronic Immune Thrombocytopenia
- Thrombocytopenia
- Adis Drug Evaluation
Julia Paik
Luspatercept: A Review in Transfusion-Dependent Anaemia due to Myelodysplastic Syndromes or β-Thalassaemia
- Myelodysplastic Syndrome
- Adis Drug Evaluation
Connie Kang, Yahiya Y. Syed
Melphalan Flufenamide (Melflufen): First Approval
- Multiple Myeloma
- AdisInsight Report
Sohita Dhillon